IFNG and graft versus host disease: In an experiment on human graft-vs.-host disease (GVHD), MSC exosomes were shown to reduce the release of interferon gamma (IFN-γ) and tumor necrosis factor alpha (TNF-α) by activated NK cells, alleviating the inflammatory response (100).